Public Health
Global health gains face reversal risks from demographic shifts and infectious diseases. Experts discuss preparedness and policies for better community outcomes.
Addressing short-termism, data gaps, and chronic disease pressures to strengthen outbreak preparedness and community health outcomes in 2026.
WASHINGTON — The Senate Health Committee on Thursday approved two nominees for key…
BOSTON — In an order issued Thursday, a federal judge denied a request…
Get the health information and medications you need every weekday with STAT’s free…
Starting next week, Nebraskans receiving Medicaid will be at risk of losing their…
Health Updates
A comprehensive overview of key clinical trials in 2025-2026, focusing on oncology, gene therapy, and vaccines for clinical researchers and practitioners.
Clinical researchers face information overload from fast-evolving medical breakthroughs. This post breaks down 2025 Phase III trial results, FDA oncology approvals, neurology advances, and emerging methodologies like adaptive designs.
Evidence-based strategies for adapting psychiatric treatments in inpatient and youth settings amid infrastructure and policy challenges.
Explore strategies to navigate funding risks and volatility in 2026 clinical trials using AI, global markets, and emerging methodologies.
Explore why legacy clinical trial designs are falling short in 2026 and how AI, adaptive designs, and decentralized models are reshaping medical research for better outcomes.